Subscribe Now Subscribe Today
Science Alert
 
FOLLOW US:     Facebook     Twitter
Blue
   
Curve Top
International Journal of Pharmacology
  Year: 2011 | Volume: 7 | Issue: 6 | Page No.: 690-696
DOI: 10.3923/ijp.2011.690.696
Effect of Nicorandil: A Potassium Channel Opener against Experimentally-induced Hyperlipidemia
Dhaval Rathod, Hordik Dodiya and Sunita Goswami

Abstract:
Hypercholesterolemia often occurs in conjunction with other metabolic risk factors including glucose intolerance, obesity, diabetes and metabolic syndromes. Nicorandil is a potassium channel opener and Nitric Oxide (NO) donor. The aim of study was to evaluate pharmacological effect of nicorandil (2 mg kg-1, orally) on different lipid levels, enzyme-hydroxymethylglutaryl Coenzyme A (HMG-CoA) reductase and antioxidant enzymes. The lipid parameters, HMG-CoA reductase activity and antioxidant enzymes were evaluated in poloxamer-407 (acute model) and high-cholesterol diet-induced hyperlipidemia (chronic model) in Sprague dawley rats. The animals were divided into four group’s viz., normal, high cholesterol diet (control), atorvastatin and nicorandil treated animals. In poloxamer-407-induced acute hyperlipidemia model, blood samples were collected at 15 and 24 h period. In high-fat diet-induced model, animals were given respective treatment for the period of twenty one days. Lipid parameters were commonly measured in both the models and compared with reference standard (atorvastatin; 50 mg kg-1). In high fat diet model, antioxidant parameters were additionally measured in the terms of lipid peroxidation (MDA), superoxide dismutase (SOD), catalase (CAT) and reduced glutathione (GSH). High cholesterol diet and poloxamer-407 caused a significant increase in lipid parameters in rats. Nicorandil pre-treatment showed a significant decrease in total cholesterol (TC), triglycerides (TG), low density lipoprotein-cholesterol (LDL-C), very low density lipoproteins-cholestero l(VLDL-C) and atherogenic index (AI) in both the models. The results were comparable with that of atorvastatin treated animals. Further, nicorandil showed significant decrease in MDA and SOD along with significant increase in GSH and CAT against high-fat diet model. Based on our data, it is suggested that nicorandil possess hypolipidemic activity. The mechanism of action of this antihyperlipidemic activity of nicorandil could be attributed to its releasing nitric oxide property and inhibiting oxidative stress.
PDF Fulltext XML References Citation Report Citation
 RELATED ARTICLES:
  •    Experimental Models for Vascular Endothelial Dysfunction
  •    Coenzyme Q10 Ameliorates Statin-related Myotoxicity: A Biochemical and Histological Study
  •    A Simple Method for Screening Antihyperlipidemic Agents
  •    Lack of Effect of Atorvastatin or Pravastatin on the Endothelium-Dependent Relaxation in Segments of Human Vessels
How to cite this article:

Dhaval Rathod, Hordik Dodiya and Sunita Goswami, 2011. Effect of Nicorandil: A Potassium Channel Opener against Experimentally-induced Hyperlipidemia. International Journal of Pharmacology, 7: 690-696.

DOI: 10.3923/ijp.2011.690.696

URL: https://scialert.net/abstract/?doi=ijp.2011.690.696

 
COMMENT ON THIS PAPER
 
 
 

 

 
 
 
 
 
 
 
 
 

 
 
 
 
 
 
 
 
 
 
 

       

       

Curve Bottom